Peizhi (Peter) Luo

Title: Innovations of Peizhi (Peter) Luo

Introduction

Peizhi (Peter) Luo is an accomplished inventor based in Lansdale, PA (US). He has made significant contributions to the field of biochemistry, particularly in the development of PCSK9 antagonists. With a total of 2 patents to his name, his work has the potential to impact the treatment of various health conditions.

Latest Patents

Luo's latest patents include 1B20 and 1D05, both focusing on PCSK9 antagonists. These antagonists are designed to inhibit the function of human proprotein convertase subtilisin-kexin type 9 (PCSK9). The disclosed antagonists are effective in treating conditions associated with PCSK9 activity. Additionally, the patents cover nucleic acids encoding these antagonists, vectors, host cells, and compositions that include the antagonists. Methods for creating PCSK9-specific antagonists and their applications in inhibiting or antagonizing PCSK9 function are also detailed in these patents.

Career Highlights

Throughout his career, Peizhi (Peter) Luo has worked with notable companies such as Merck Sharp & Dohme Corporation and Merck Sharpe & Dohme Corp. His experience in these organizations has contributed to his expertise in the field of biochemistry and pharmaceutical innovations.

Collaborations

Luo has collaborated with several professionals in his field, including Jon H Condra and Rose M Cubbon. These collaborations have likely enriched his research and development efforts.

Conclusion

Peizhi (Peter) Luo is a notable inventor whose work on PCSK9 antagonists holds promise for advancing medical treatments. His contributions to the field are significant and reflect his dedication to innovation in biochemistry.